Bogdana Suchorska

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 556 citations · Full text

Hematological Malignancy, Neuro-oncology, Treatment Strategies +13

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial

Bogdana Suchorska, Michael Weller, Ghazaleh Tabatabai et al. · Neuro-Oncology · 2016 · 246 citations · Full text

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

Nathalie Jansen, Vera Graute, Lena Armbruster et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 181 citations

Positron Emission Tomography, Mri-suspected Low-grade Glioma, Medical Imaging +12

Biological tumor volume in ¹⁸ FET-PET before radiochemotherapy correlates with survival in GBM

Bogdana Suchorska, Nathalie Jansen, Jennifer Linn et al. · Neurology · 2015 · 171 citations · Full text

Prognostic Significance of Dynamic ¹⁸F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma

Nathalie Jansen, Bogdana Suchorska, Vera Wenter et al. · Journal of Nuclear Medicine · 2014 · 152 citations